The Hydration Pharmaceuticals Co (ASX:HPC) ROCE %: -205.42% (As of Dec. 2025)


What is The Hydration Pharmaceuticals Co ROCE %?

The Hydration Pharmaceuticals Co ASX:HPC -20.00% ROCE % is -205.42% as of Dec. 2025. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. The Hydration Pharmaceuticals Co's annualized ROCE % for the quarter that ended in Dec. 2025 was -205.42%.

The Hydration Pharmaceuticals Co  (ASX:HPC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

The Hydration Pharmaceuticals Co ROCE % Related Terms

The Hydration Pharmaceuticals Co ROCE % Historical Data

* Premium members only.

The historical data trend for The Hydration Pharmaceuticals Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co ROCE % Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
-40.10 -103.89 -133.09 -127.62 -127.42

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only -338.93 -122.85 -241.49 -94.11 -205.42

The Hydration Pharmaceuticals Co ROCE % Calculation

The Hydration Pharmaceuticals Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-4.14/( ( (7.889 - 3.526) + (3.3 - 1.165) )/ 2 )
=-4.14/( (4.363+2.135)/ 2 )
=-4.14/3.249
=-127.42 %

The Hydration Pharmaceuticals Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-5.006/( ( (3.946 - 1.207) + (3.3 - 1.165) )/ 2 )
=-5.006/( ( 2.739 + 2.135 )/ 2 )
=-5.006/2.437
=-205.42 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -205.42% mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a ROCE % of -205.42% as of Dec. 2025.
Is The Hydration Pharmaceuticals Co's ROCE % too high?
The Hydration Pharmaceuticals Co's current ROCE % is -205.42%.
How does The Hydration Pharmaceuticals Co's ROCE % compare to SYY and USFD?
The Hydration Pharmaceuticals Co's ROCE % of -205.42% can be compared against companies in the Retail - Defensive industry. The industry median ROCE % is 8.98. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Retail - Defensive company?
The median ROCE % among Retail - Defensive companies is 8.98, based on 307 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Retail - Defensive industry, the median ROCE % is 8.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current ROCE % is -205.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current ROCE % of -205.42%. The current ROCE % is -205.42%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current ROCE % is -205.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Hydration Pharmaceuticals Co Business Description

Address 6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.